Exane Asset Management’s Labcorp LH Stock Holding History

Exane Asset Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,873	Closed	-$279K	–	142
2018 Q3	$279K	Buy	+1,873	New	+$285K	0.09%	57

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Asset Management's LH Position: Q4 2018 in Review

Exane Asset Management sold out of Labcorp (LH) in Q4 2018, closing a stake of 1,873 shares — an estimated $279K sold.

Exane Asset Management first reported a position in LH in Q3 2018 and held it in 1 quarter. The position peaked at $279K in Q3 2018. 742 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Exane Asset Management reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Exane Asset Management sold 1,873 Labcorp shares in Q4 2018, an estimated $279K.
Exane Asset Management first reported a position in Labcorp in Q3 2018 and held it in 1 quarter.
Exane Asset Management's Labcorp position peaked at $279K in Q3 2018.
742 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Exane Asset Management's 13F filing for Q4 2018, filed 5 Feb 2019.